Description of a multidisciplinary model of care in a French cohort of adult patients with tuberous sclerosis complex

被引:4
作者
Pfirmann, Pierre [1 ,2 ]
Aupy, Jerome [3 ]
Jambon, Eva [4 ]
Idier, Laetitia [1 ,5 ]
Prezelin-Reydit, Mathilde [5 ,6 ]
Fermis, Marine [7 ]
Devillard, Raphael [2 ,7 ]
Grenier, Nicolas [4 ]
Combe, Christian [1 ,2 ]
Rigothier, Claire [1 ,2 ]
机构
[1] Ctr Hosp Univ Bordeaux, Serv Nephrol Transplantat Dialyse & Aphereses, F-33000 Bordeaux, France
[2] INSERM DR Aquitaine Poitou Charentes, U1026, BioTis, Tissue Bioengn, Bordeaux, France
[3] Ctr Hosp Univ Bordeaux, Serv Neurol, Bordeaux, France
[4] Ctr Hosp Univ Bordeaux, Serv Imagerie Med, Bordeaux, France
[5] Assoc Utilisat Rein Artificiel Domicile Aquitaine, Gradignan, France
[6] Bordeaux Populat Hlth Res Ctr, INSERM, ISPED, Bordeaux, France
[7] Ctr Hosp Univ Bordeaux, Serv Med Bucco Dentaire, Bordeaux, France
关键词
tuberous sclerosis complex; registry; mTOR inhibitor; renal angiomyolipoma; quality of life; IDENTIFICATION; MOSAICISM; GENE;
D O I
10.1136/jmedgenet-2019-106607
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Background Tuberous sclerosis complex (TSC) is a rare autosomal dominant genetic disorder. Due to the various manifestations of TSC and their potential complications, a multidisciplinary care approach is recommended by consensus guidelines. Objectives Our study aimed to give a complete description of our TSC adult cohort and to evaluate the multidisciplinary and interdisciplinary management model. Methods Data on each adult patient diagnosed with TSC, including disease manifestations, interventions and outcomes, were collected at baseline and updated annually. A multidisciplinary TSC approach with all the recommended explorations was carried out annually. Results 90 patients were enrolled in Centre Hospitalier Universitaire de Bordeaux, between January 2000 and September 2018. Median age of patients at inclusion was 37 years (range, 27-47) and 20 years old at diagnosis of TSC. Regarding the occurrence of TSC manifestations, 97% of the patients had cutaneous lesions, 89% had neurological manifestations, 83% had renal manifestations and 100% had dental lesions with pits. More than half the patients had sclerotic bone lesions (68%), TSC-associated neuropsychiatric disorders (64%) and lymphangioleiomyomatosis (59%). A TSC multidisciplinary approach was developed including a global follow-up and an evaluation of TSC targeting organs, according to the recommendations. A satisfaction survey revealed global and entire satisfaction of patients with TSC. Conclusion We obtained an accurate description of a cohort of adult patients with TSC. Our multidisciplinary approach model allowed us to provide optimal management of patients with TSC with a high level of patient satisfaction.
引用
收藏
页码:25 / 31
页数:7
相关论文
共 31 条
  • [21] NELLIST M, 1993, CELL, V75, P1305
  • [22] Prevalence of tuberous sclerosis estimated by capture-recapture analysis
    O'Callaghan, FJK
    Shiell, IW
    Osborne, JP
    Martyn, CN
    [J]. LANCET, 1998, 351 (9114) : 1490 - 1490
  • [23] Renal manifestations of tuberous sclerosis complex: Incidence, prognosis, and predictive factors
    Rakowski, S. K.
    Winterkorn, E. B.
    Paul, E.
    Steele, D. J. R.
    Halpern, E. F.
    Thiele, E. A.
    [J]. KIDNEY INTERNATIONAL, 2006, 70 (10) : 1777 - 1782
  • [24] Association of Malnutrition-inflammation Score With Quality of Life and Mortality in Hemodialysis Patients: A 5-Year Prospective Cohort Study
    Rambod, Mehdi
    Bross, Rachelle
    Zitterkoph, Jennifer
    Benner, Deborah
    Pithia, Juhi
    Colman, Sara
    Kovesdy, Csaba P.
    Kopple, Joel D.
    Kalantar-Zadeh, Kamyar
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 2009, 53 (02) : 298 - 309
  • [25] Caring for Children With Tuberous Sclerosis Complex: What Is the Physical and Mental Health Impact on Caregivers?
    Rentz, Anne M.
    Skalicky, Anne M.
    Pashos, Chris L.
    Liu, Zhimei
    Magestro, Matthew
    Pelletier, Corey L.
    Prestifilippo, Judith A.
    Nakagawa, JoAnne
    Frost, Michael D.
    Dunn, David W.
    Wheless, James W.
    [J]. JOURNAL OF CHILD NEUROLOGY, 2015, 30 (12) : 1574 - 1581
  • [26] CAUSES OF DEATH IN PATIENTS WITH TUBEROUS SCLEROSIS
    SHEPHERD, CW
    GOMEZ, MR
    LIE, JT
    CROWSON, CS
    [J]. MAYO CLINIC PROCEEDINGS, 1991, 66 (08) : 792 - 796
  • [27] Shepherd CW., 1991, ANN NY ACAD SCI, V615, P375, DOI 10.1111/j.1749-6632.1991.tb37786.x
  • [28] Mosaic and Intronic Mutations in TSC1/TSC2 Explain the Majority of TSC Patients with No Mutation Identified by Conventional Testing
    Tyburczy, Magdalena E.
    Dies, Kira A.
    Glass, Jennifer
    Camposano, Susana
    Chekaluk, Yvonne
    Thorner, Aaron R.
    Lin, Ling
    Krueger, Darcy
    Franz, David N.
    Thiele, Elizabeth A.
    Sahin, Mustafa
    Kwiatkowski, David J.
    [J]. PLOS GENETICS, 2015, 11 (11):
  • [29] Identification of the tuberous sclerosis gene TSC1 on chromosome 9q34
    vanSlegtenhorst, M
    deHoogt, R
    Hermans, C
    Nellist, M
    Janssen, B
    Verhoef, S
    Lindhout, D
    vandenOuweland, A
    Halley, D
    Young, J
    Burley, M
    Jeremiah, S
    Woodward, K
    Nahmias, J
    Fox, M
    Ekong, R
    Osborne, J
    Wolfe, J
    Povey, S
    Snell, RG
    Cheadle, JP
    Jones, AC
    Tachataki, M
    Ravine, D
    Sampson, JR
    Reeve, MP
    Richardson, P
    Wilmer, F
    Munro, C
    Hawkins, TL
    Sepp, T
    Ali, JBM
    Ward, S
    Green, AJ
    Yates, JRW
    Kwiatkowska, J
    Henske, EP
    Short, MP
    Haines, JH
    Jozwiak, S
    Kwiatkowski, DJ
    [J]. SCIENCE, 1997, 277 (5327) : 805 - 808
  • [30] SOMATIC MOSAICISM AND CLINICAL VARIATION IN TUBEROUS SCLEROSIS COMPLEX
    VERHOEF, S
    VRTEL, R
    VANESSEN, T
    BAKKER, L
    SIKKENS, E
    HALLEY, D
    LINDHOUT, D
    VANDENOUWELAND, A
    [J]. LANCET, 1995, 345 (8943): : 202 - 202